Hypoxia regulates CD9-mediated keratinocyte migration via the P38/MAPK pathway

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Jiang, Xupin ^a   Guo, Xiaowei ^a   Xu, Xue ^b   Teng, Miao ^c   Huang, Chong ^a   Zhang, Dongxia ^a   Zhang, Qiong ^a   Zhang, Jiaping ^a   Huang, Yuesheng ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b No 324 Hospital of Chengdu Military Region   (China)

^c THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CD9 ANTIGEN; CD9 PROTEIN, HUMAN; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; MAP2K6 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE P38; PYRIDINE DERIVATIVE;

ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL HYPOXIA; CELL MOTION; DOWN REGULATION; DRUG EFFECTS; GENETICS; HUMAN; KERATINOCYTE; METABOLISM; MOUSE; PHYSIOLOGY; WOUND HEALING;

ANIMALS; ANTIGENS, CD9; CELL HYPOXIA; CELL MOVEMENT; DOWN-REGULATION; ENZYME INHIBITORS; HUMANS; IMIDAZOLES; KERATINOCYTES; MAP KINASE KINASE 6; MICE; MICE, INBRED BALB C; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; WOUND HEALING;

EID: 84923275896     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06304     Document Type: Article

References (62)

1. Miyake, M. et al. Suppression of pulmonary metastasis using adenovirally motility related protein-1 (MRP-1/CD9) gene delivery. Oncogene 19, 5221-5226 (2000).
2. Garcia-Lopez, M. A., Barreiro, O., Garcia-Diez, A., Sanchez-Madrid, F. & Penas, P. F. Role of tetraspanins CD9 and CD151 in primary melanocyte motility. J Invest Dermatol 125, 1001-1009 (2005).
3. Powner, D., Kopp, P. M., Monkley, S. J., Critchley, D. R. & Berditchevski, F. Tetraspanin CD9 in cell migration. Biochem Soc Trans 39, 563-567 (2011).
4. Deissler, H., Kuhn, E. M. & Lang, G. E. Tetraspanin CD9 is involved in the migration of retinal microvascular endothelial cells. Int J Mol Med 20, 643-652 (2007).
5. Masellis-Smith, A. & Shaw, A. R. CD9-regulated adhesion. Anti-CD9 monoclonal antibody induce pre-B cell adhesion to bone marrow fibroblasts through de novo recognition of fibronectin. J Immunol 152, 2768-2777 (1994).
6. Kawano, N. et al. Absence of CD9 reduces endometrial VEGF secretion and impairs uterine repair after parturition. Sci Rep 4, 4701 (2014).
7. Zhang, J. P. et al. CD9 Is Critical for Cutaneous Wound Healing through JNK Signaling. J Invest Dermatol 132, 226-236 (2012).
8. Jiang, X. P. et al. Downregulation of CD9 in Keratinocyte Contributes to Cell Migration via Upregulation of Matrix Metalloproteinase-9. Plos One 8, e77806 (2013).
9. Martin, P. Wound healing-aiming for perfect skin regeneration. Science 276, 75-81 (1997).
10. Raja, Sivamani, K., Garcia, M. S. & Isseroff, R. R. Wound re-epithelialization: modulating keratinocyte migration in wound healing. Front Biosci 12, 2849-2868 (2007).
11. O'Toole, E. A. et al.Hypoxia increases human keratinocyte motility on connective tissue. J Clin Invest 100, 2881-2891 (1997).
12. Hunt, T. K., Niinikoski, J. & Zederfeldt, B. Role of oxygen in repair processes. Acta Chir Scand 138, 109-110 (1972).
13. Niinikoski, J., Hunt, T. K. & Dunphy, J. E. Oxygen supply in healing tissue. Am J Surg 123, 247-252 (1972).
14. Tandara, A. A. &Mustoe, T. A. Oxygen in wound healing-more than a nutrient. World J Surg 28, 294-300 (2004).
15. Moeller, B. J. et al. The relationship between hypoxia and angiogenesis. Semin Radiat Oncol 14, 215-221 (2004).
16. Ridgway, P. F., Ziprin, P., Peck, D. H. & Darzi, A. W. Hypoxia increases reepithelialization via an alphavbeta6-dependent pathway. Wound Repair Regen 13, 158-164 (2005).
17. Ninikoski, J., Heughan, C. & Hunt, T. K. Oxygen tensions in human wounds. J Surg Res 12, 77-82 (1972).
18. Xing, D. et al. Hypoxia and hypoxia-inducible factor in the burn wound. Wound Repair Regen 19, 205-213 (2011).
19. Xia, Y. P., Zhao, Y., Tyrone, J. W., Chen, A. &Mustoe, T. A. Differential activation of migration by hypoxia in keratinocytes isolated from donors of increasing age: implication for chronic wounds in the elderly. J Invest Dermatol 116, 50-56 (2001).
20. O'Toole, E. A., van Koningsveld, R., Chen, M. &Woodley, D. T. Hypoxia induces epidermal keratinocyte matrix metalloproteinase-9 secretion via the protein kinase C pathway. J Cell Physiol 214, 47-55 (2008).
21. Chien, C. W. et al. Regulation of CD151 by hypoxia controls cell adhesion and metastasis in colorectal cancer. Clin Cancer Res 14, 8043-8051 (2008).
22. Semenza, G. L. Does loss of CD151 expression promote the metastasis of hypoxic colon cancer cells? Clin Cancer Res 14, 7969-7970 (2008).
23. Iida, H., Suzuki, M., Goitsuka, R. & Ueno, H. Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2. Int J Oncol 40, 71-79 (2012).
24. Fan, B., Wang, Y. X., Yao, T. & Zhu, Y. C. p38 Mitogen-activated protein kinase mediates hypoxia-induced vascular endothelial growth factor release in human endothelial cells. Sheng li xue bao 57, 13-20 (2005).
25. Zheng, M. et al. Intracellular acidosis-activated p38 MAPK signaling and its essential role in cardiomyocyte hypoxic injury. Faseb J 19, 109-111 (2005).
26. Haddad, J. J. & Hanbali, L. B. Hypoxia upregulates MAPK(p38)/MAPK(ERK) phosphorylation in vitro: neuroimmunological differential time-dependent expression of MAPKs. Protein Pept Lett 21, 444-451 (2014).
27. Harper, E. G., Alvares, S. M. & Carter, W. G. Wounding activates p38 map kinase and activation transcription factor 3 in leading keratinocytes. J Cell Sci 118, 3471-3485 (2005).
28. Li, W. et al. The p38-MAPK/SAPK pathway is required for human keratinocyte migration on dermal collagen. J Invest Dermatol 117, 1601-1611 (2001).
29. Sharma, G. D., He, J. & Bazan,H. E. p38 and ERK1/2 coordinate cellular migration and proliferation in epithelial wound healing: evidence of cross-talk activation between MAP kinase cascades. J Biol Chem 278, 21989-21997 (2003).
30. Stoll, S. W., Kansra, S. & Elder, J. T. Keratinocyte outgrowth from human skin explant cultures is dependent upon p38 signaling. Wound Repair Regen 11, 346-353 (2003).
31. Raingeaud, J., Whitmarsh, A. J., Barrett, T., Derijard, B. & Davis, R. J. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol 16, 1247-1255 (1996).
32. Gurtner, G. C., Werner, S., Barrandon, Y. & Longaker, M. T. Wound repair and regeneration. Nature 453, 314-321 (2008).
33. Garlick, J. A., Parks, W. C., Welgus, H. G. & Taichman, L. B. Re-epithelialization of human oral keratinocytes in vitro. J Dent Res 75, 912-918 (1996).
34. Klein-Soyer, C., Azorsa, D. O., Cazenave, J. P. & Lanza, F. CD9 participates in endothelial cell migration during in vitro wound repair. Arterioscler Thromb Vasc Biol 20, 360-369 (2000).
35. Ninikoski, J., Heughan, C. & Hunt, T. K. Oxygen and carbon dioxide tensions in experimental wounds. Surg Gynecol Obstet 133, 1003-1007 (1971).
36. Goodson,W.H. 3rd, Andrews, W. S., Thakral, K. K. &Hunt, T. K. Wound oxygen tension of large vs small wounds in man. Surg Forum 30, 92-95 (1979).
37. Lokmic, Z., Musyoka, J., Hewitson, T. D. & Darby, I. A. Hypoxia and hypoxia signaling in tissue repair and fibrosis. Int Rev Cell Mol Biol 296, 139-185 (2012).
38. Haroon, Z. A., Raleigh, J. A., Greenberg, C. S. & Dewhirst, M. W. Early wound healing exhibits cytokine surge without evidence of hypoxia. Ann Surg 231, 137-147 (2000).
39. Lokmic, Z., Darby, I. A., Thompson, E.W. & Mitchell, G. M. Time course analysis of hypoxia, granulation tissue and blood vessel growth, and remodeling in healing rat cutaneous incisional primary intention wounds. Wound Repair Regen 14, 277-288 (2006).
40. Eaglstein, W.H. Experiences with biosynthetic dressings. J Am Acad Dermatol 12, 434-440 (1985).
41. Falanga, V. Occlusive wound dressings. Why, when, which? Arch Dermato 124, 872-877 (1988).
42. Alper, J. C., Welch, E. A., Ginsberg, M., Bogaars, H. & Maguire, P. Moist wound healing under a vapor permeable membrane. J Am Acad Dermatol 8, 347-353 (1983).
43. Eaglstein, W. H., Davis, S. C., Mehle, A. L. & Mertz, P. M. Optimal use of an occlusive dressing to enhance healing. Effect of delayed application and early removal on wound healing. Arch Dermato 124, 392-395 (1988).
44. Mani, R.,White, J. E., Barrett, D. F. &Weaver, P. W. Tissue oxygenation, venous ulcers and fibrin cuffs. J R Soc Med 82, 345-346 (1989).
45. Hemler, M. E. Targeting of tetraspanin proteins-potential benefits and strategies. Nat Rev Drug Discov 7, 747-758 (2008).
46. Penas, P. F., Garcia-Diez, A., Sanchez-Madrid, F. & Yanez-Mo, M. Tetraspanins are localized at motility-related structures and involved in normal human keratinocyte wound healing migration. J Invest Dermatol 114, 1126-1135 (2000).
47. Bassani, S. & Cingolani, L. A. Tetraspanins: Interactions and interplay with integrins. Int J Biochem Cell Biol 44, 703-708 (2012).
48. Baudoux, B., Castanares-Zapatero, D., Leclercq-Smekens, M., Berna, N. & Poumay, Y. The tetraspanin CD9 associates with the integrin alpha6beta4 in cultured human epidermal keratinocytes and is involved in cell motility. Eur J Cell Biol 79, 41-51 (2000).
49. Jones, P. H., Bishop, L. A. & Watt, F. M. Functional significance of CD9 association with beta 1 integrins in human epidermal keratinocytes. Cell Adhes Commun 4, 297-305 (1996).
50. Karroum, A. et al. Matrix metalloproteinase-9 is required for tubular network formation and migration of resistant breast cancer cells MCF-7 through PKC and ERK1/2 signalling pathways. Cancer Lett 295, 242-251 (2010).
51. Hsu, J. Y. C. et al. Matrix Metalloproteinase-9 Facilitates Glial Scar Formation in the Injured Spinal Cord. J Neurosci 28, 13467-13477 (2008).
52. Wang, H.-X., Li, Q., Sharma, C., Knoblich, K. & Hemler, M. E. Tetraspanin protein contributions to cancer. Biochem Soc Trans 39, 547-552 (2011).
53. Anton, E. S., Hadjiargyrou, M., Patterson, P. H. & Matthew, W. D. CD9 plays a role in Schwann cell migration in vitro. J Neurosci 15, 584-595 (1995).
54. Buim, M. E. et al. Downregulation of CD9 protein expression is associated with aggressive behavior of oral squamous cell carcinoma. Oral Oncol 46, 166-171 (2010).
55. Furuya, M. et al.Down-regulation of CD9 in human ovarian carcinoma cell might contribute to peritoneal dissemination: Morphologic alteration and reduced expression of beta 1 integrin subsets. Cancer Res 65, 2617-2625 (2005).
56. Bienes-Martinez, R. et al. Autocrine stimulation of clear-cell renal carcinoma cell migration in hypoxia via HIF-independent suppression of thrombospondin-1. Sci Rep 2, 788 (2012).
57. Welsh, S. J. et al. Inhibition of the hypoxia-inducible factor pathway by a Gquadruplex binding small molecule. Sci Rep 3, 2799 (2013).
58. Wang, J. C. et al. Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications. Clin Cancer Res 13, 2354-2361 (2007).
59. An, S. S. et al. Hypoxia alters biophysical properties of endothelial cells via p38 MAPK- and Rho kinase-dependent pathways. Am J Physiol Cell Physiol 289, C521-530 (2005).
60. Qiao, H. et al. Collagen XVII participates in keratinocyte adhesion to collagen IV, and in p38MAPK-dependent migration and cell signaling. J Invest Dermatol 129, 2288-2295 (2009).
61. Fitsialos, G. et al. Transcriptional signature of epidermal keratinocytes subjected to in vitro scratch wounding reveals selective roles for ERK1/2, p38, and phosphatidylinositol 3-kinase signaling pathways. J Biol Chem 282, 15090-15102 (2007).
62. Paladini, R. D. & Coulombe, P. A. Directed expression of keratin 16 to the progenitor basal cells of transgenic mouse skin delays skin maturation. J Cell Biol 142, 1035-1051 (1998).